Fresenius MedCare: Jefferies downgrades stock
(CercleFinance.com) - Jefferies has downgraded the Fresenius Medical Care stoc to "hold," having cut its corresponding target price from 70 euros to 68 euros, despite raising its 2020 EPS estimate for the German dialysis specialist.
"The risk/reward isn't favourable into 2H given a 13% share price increase YTD in a challenging period for the HC Services sector overall," the broker said.
Jefferies considers that the CMD scheduled for October could cast light on the group's MT growth engines, although it believes that the share's price does not adequately integrate ST risks around the group.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.